Carcinoid Tumors
March 2021 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Primary renal carcinoid tumors: Three case reports.
Authors:Chen Y, Shu Y, He L, Wu K
Institution:Department of Radiology, The First Affiliated Hospital of Nanchang University.
Journal:Medicine (Baltimore). 2021 Feb 26;100(8):e24714. doi: 10.1097/MD.0000000000024714.

2:Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.
Authors:Rodriguez-Freixinos V, Capdevila J, Pavel M, Thawer A, Baudin E, O'Toole D, Herrmann K, Welin S, Grozinsky-Glasberg S, de Herder WW, Valle JW, Herman J, Kolarova T, Bouvier C, Falconi M, Ferone D, Singh S
Institution:Department of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: Simron.Singh@sunnybrook.ca.
Journal:Eur J Cancer. 2021 Feb;144:200-214. doi: 10.1016/j.ejca.2020.11.037. Epub 2020 Dec 25.

3:Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States.
Authors:Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ
Institution:Tulane University School of Medicine, New Orleans, Louisiana (E.M.M., W.A.). Southeastern Louisiana Veterans Healthcare System and Tulane University School of Medicine, New Orleans, Louisiana (J.J.K.).
Journal:Ann Intern Med. 2021 Feb;174(2):157-166. doi: 10.7326/M20-0068. Epub 2020 Dec 15.

4:Chromogranin A assessment in patients with neuroendocrine neoplasm of the small bowel and carcinoid syndrome treated with somatostatin analogues.
Authors:Gut P, Czarnywojtek A, RuchaƂa M
Institution:Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poland.
Journal:Adv Clin Exp Med. 2020 Nov;29(11):1319-1324. doi: 10.17219/acem/126290.

5:Cancer-associated retinopathy preceding the diagnosis of a pulmonary carcinoid tumour.
Authors:Merle G, Baglivo E, Younossian AB, Vijgen S, Karenovics W, Kherad O
Institution:Internal Medicine Division, Hopital de la Tour, Geneva, Switzerland. Internal Medicine Division, Hopital de la Tour, Geneva, Switzerland omar.kherad@latour.ch.
Journal:BMJ Case Rep. 2020 Nov 2;13(11):e235046. doi: 10.1136/bcr-2020-235046.

6:Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.
Authors:Little BP, Junn JC, Zheng KS, Sanchez FW, Henry TS, Veeraraghavan S, Berkowitz EA
Institution:Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114. Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA.
Journal:AJR Am J Roentgenol. 2020 Dec;215(6):1312-1320. doi: 10.2214/AJR.19.22628. Epub 2020 Oct 6.

7:Primary ovarian carcinoid: Two cases report and review of literature.
Authors:Zhai LR, Zhang XW, Yu T, Jiang ZD, Huang DW, Jia Y, Cui MH
Institution:Department of gynecology and Obstetrics.
Journal:Medicine (Baltimore). 2020 Oct 2;99(40):e21109. doi: 10.1097/MD.0000000000021109.

8:Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.
Authors:Dong S, Liang J, Zhai W, Yu Z
Institution:Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province.
Journal:Am J Clin Oncol. 2020 Sep;43(9):607-614. doi: 10.1097/COC.0000000000000715.

9:Multiple atypical thymic carcinoids with paraneoplastic giant cell arteritis.
Authors:Nakayama T, Katagiri S, Kikkawa T, Obara T, Mori T, Kiriu T
Institution:Department of General Thoracic Surgery, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8524, Japan. nakayama-takashi-0901@hotmail.co.jp. Department of Pathology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Journal:Gen Thorac Cardiovasc Surg. 2020 Oct;68(10):1212-1215. doi: 10.1007/s11748-019-01230-3. Epub 2019 Oct 17.

10:Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea.
Authors:Dasari A, Joish VN, Perez-Olle R, Dharba S, Balaji K, Halperin DM
Institution:Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.
Journal:Expert Rev Pharmacoecon Outcomes Res. 2020 Oct;20(5):507-511. doi: 10.1080/14737167.2019.1660646. Epub 2019 Aug 26.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: July 1, 2021
212 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT13931029

Coupon Expires: October 18, 2021



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2021 Medifocus, Inc. All rights reserved.